durapatite has been researched along with aluminum chloride in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christoffersen, J; Christoffersen, MR; Thyregod, HC | 1 |
| Levy, RJ; Ogle, M; Schoen, FJ; Vyavahare, N | 1 |
| Darwish, AS; Kamal, SM; Wahba, SM | 1 |
3 other study(ies) available for durapatite and aluminum chloride
| Article | Year |
|---|---|
Effects of aluminum(III), chromium(III), and iron(III) on the rate of dissolution of calcium hydroxyapatite crystals in the absence and presence of the chelating agent desferrioxamine.
Topics: Adsorption; Aluminum; Aluminum Chloride; Aluminum Compounds; Chlorides; Chromium; Chromium Compounds; Crystallization; Deferoxamine; Durapatite; Ferric Compounds; Humans; Hydroxyapatites; Nitrates; Solubility; Solutions | 1987 |
Elastin calcification and its prevention with aluminum chloride pretreatment.
Topics: Aluminum Chloride; Aluminum Compounds; Amino Acids; Animals; Calcinosis; Cattle; Chlorides; Circular Dichroism; Disease Models, Animal; Durapatite; Elastin; Glutaral; Implants, Experimental; Magnetic Resonance Spectroscopy; Rats; Skin; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 1999 |
Ceria-containing uncoated and coated hydroxyapatite-based galantamine nanocomposites for formidable treatment of Alzheimer's disease in ovariectomized albino-rat model.
Topics: Aluminum Chloride; Aluminum Compounds; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cerebral Cortex; Cerium; Chitosan; Chlorides; Disease Models, Animal; Drug Carriers; Durapatite; Dynamic Light Scattering; Female; Galantamine; Hippocampus; Nanocomposites; Ovariectomy; Rats; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2016 |